Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pediatric Exclusivity Rules May Be Revisited

This article was originally published in The Pink Sheet Daily

Executive Summary

The rules governing pediatric exclusivity awards may be revisited as a result of the investigation into the handling of pediatric antidepressant safety data

You may also be interested in...



Sen. Gregg Plans Clinical Trials Legislation For This Congressional Session

The Senate Health Committee chairman’s bill would focus on “clinical trial database issues,” while legislation planned by Sens. Kennedy, Dodd and Johnson would be directed at FDA’s authority to disclose clinical trial results, a committee staffer says.

Sen. Gregg Plans Clinical Trials Legislation For This Congressional Session

The Senate Health Committee chairman’s bill would focus on “clinical trial database issues,” while legislation planned by Sens. Kennedy, Dodd and Johnson would be directed at FDA’s authority to disclose clinical trial results, a committee staffer says.

PhRMA Clinical Trial Registry Will Be Launched Oct. 1

Clinicalstudyresults.org will include results of all controlled “hypothesis testing” clinical trials completed since October 2002 for PhRMA member companies’ marketed products. Postings will include a drug’s label, a bibliography of published studies, and summaries of unpublished studies.

Topics

UsernamePublicRestriction

Register

LL016789

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel